Centurion Wealth Management’s BlackRock US Equity Factor Rotation ETF DYNF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.47M Sell
122,234
-10,735
-8% -$738K 2.04% 9
2026
Q2
$9.04M Sell
132,969
-21,694
-14% -$1.41M 2.16% 7
2026
Q1
$9M Buy
154,663
+2,110
+1% +$128K 2.03% 8
2025
Q4
$9.28M Buy
152,553
+8,577
+6% +$516K 2.03% 7
2025
Q3
$8.52M Buy
143,976
+13,221
+10% +$750K 1.94% 8
2025
Q2
$7.12M Buy
130,755
+6,235
+5% +$313K 2.04% 10
2025
Q1
$6.38M Hold
124,520
– – 2% 14
2024
Q4
$6.38M Sell
124,520
-1,690
-1% -$87K 2% 14
2024
Q3
$6.24M Buy
+126,210
New +$6.01M 1.99% 12
2024
Q1
$4.19M Buy
+94,269
New +$3.96M 1.65% 15

Other funds holding DYNF

Centurion Wealth Management's DYNF Position: Q3 2026 in Review

Centurion Wealth Management reduced its BlackRock US Equity Factor Rotation ETF (DYNF) stake by 8.1% in Q3 2026, selling an estimated $738K and leaving 122,234 shares worth $8.47M. The position accounts for 2.04% of the portfolio, ranked #9.

Centurion Wealth Management first reported a position in DYNF in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.28M in Q4 2025. 239 funds tracked by Wall St. Rank hold DYNF as of Q3 2026.

  • Centurion Wealth Management held 122,234 shares of BlackRock US Equity Factor Rotation ETF worth $8.47M as of Q3 2026.
  • Centurion Wealth Management sold 10,735 BlackRock US Equity Factor Rotation ETF shares in Q3 2026, an estimated $738K.
  • BlackRock US Equity Factor Rotation ETF made up 2.04% of Centurion Wealth Management's portfolio in Q3 2026, its #9 holding.
  • Centurion Wealth Management first reported a position in BlackRock US Equity Factor Rotation ETF in Q1 2024 and has held it in 10 quarters since.
  • Centurion Wealth Management's BlackRock US Equity Factor Rotation ETF position peaked at $9.28M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held BlackRock US Equity Factor Rotation ETF as of Q3 2026.

Based on Centurion Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.